Member Info for CHELSEA7

Val Ju, don"t really want to speak about VAL anymore, i have given my views, tis a case of what happens at the end of the day.

Yeah im 62, my father died on Xmas Day 2012, mother a year later on the day i was first diagnosed!!! Your post did touch me when you spoke of your mothers struggles, same as mine, just enjoy Xmas, good memories, and yes for many people Xmas is full of bad stuff, my advice, just enjoy it. Take care.

Ruck, tend to agree with you re current SP, just got a feeling we will get IND before New Year. Just a feeling, but will be a good lead into 2019

Val Ju, even yesterday sellswere 1.105/6 all others were buys. Not sure why 1.30 is showing as ask. Will tick down.

Hope alls well with you.

Interesting...............................

Professor Ola S Winqvist MD PhD is a Professor of Cellular Immunotherapy at the Karolinska Institute and Senior Consultant in Clinical Immunology at the Karolinska University Hospital. Professor Winqvist received his medical qualification in 1991 at the University of Uppsala. He then went on to achieve a PhD, focusing on experimental medicine and autoantigens in Addison's disease. He held a post-doctoral position at the Scripps Research Institute in California for three years and was Chairman of the Swedish Clinical Immunology Society until 2017.

More familiar names to the jigsaw.................................

Dr Adam Hill, CEO of Oncimmune commented: "Oncimmune's forward strategy is designed to unlock the latent potential in the Company's immunogenic protein platform, through developing a number of commercial propositions, underpinned by leading immunodiagnostic science. I am delighted that Professor Johnson, preeminent as an authority in cancer and immunology, has accepted our offer to Chair the Company's new SB, leading a team of experts, namely Dr Roope, Dr Pashayan and Prof Winqvist, who are all leaders in their chosen fields at the intersection of Cancer and Immunology, as well as medical practitioners. I look forward to working with them, leveraging their expertise as we deliver the next chapter of Oncimmune's growth over the next three years.

https://www.investegate.co.uk/oncimmune-hldngs-plc--onc-/rns/oncimmune-appoints-new-scientific-board/201812130700023173K/Professor Peter W.M Johnson appointed as Chairman of Scientific Board comprising leading cancer experts.

Theres a face we know. ATB

Does that not suggest a lot of forward selling to be done??

Just one sentence from one of your posts over the weekend was directed at ratcliffewriter....................""".people like ratcliffewritter talks and talks but they don't back anything up, like a lot of people here... These are just my findings and NOT gospel, this is AIM!!!""". He is possibly one of the best posters on AIM has given reasons for his opinion at every juncture. Which is far away than the rampers who have nacked up nothing, refuse to answer basic questions and resort to demonising better posters by accusing them of something they have never done.

So you now believe February is the time for news, based on what??? Just add IYHO, it is not a fact just another guess as the timeline slips further away. Along with a couple more your Advice is buy, didn"t know you were qualified to give financial advice, against all of LSEs rules.

I really don"t blame you for talking up a share you are in, but why do you have to make false statements for effect. i know myself i posted all the RNSs received, added how they have been interpretted , impossible to back up, but say it enough it becomes a fact. Whether it be positive or negative everybody has a right of opinion, it wouldbe good to hear what developments have taken place to warrent such confidence. Why do you think the third week in February is now the date for news??

I remember this time last year forecasts were before Xmas or just after, steadily increasing all year, now you are saying February. For allv this new found confidence the SP closed 1.10/1.30 a few buyers buying around 1.30/1.40 and signs of forward selling becoming clearer., with any funding looking conceivable around..75/.80.

jjp i do hope you clear your average, but dont post false info about posters, don"t forget those who have warned about direction of SP, the price of the next fundind are the only ones to call this right so far, and for that are on the receiving end of personal attacks, aimed at damaging their credibility which has been spot on. Lets see whether 1p can be held this week. ATB

Evening Ivy, yeah a great win. It kept me up to 7.30, after sleeping 24 hours, so was i pleased to hear that final whistle.BTW thanks for your message the other day, appreciated.

Really hoping we get that IND news on SCIB 1 before Xmas, I can possibly see a few tipsters pushing our name forward in the coming weeks and that with the IND might just act as a catalyst to better SP days.

Will be keeping up with you guys till the New Year, I have a crazy schedule, again starting Monday, needs my best head forward and all the strength i can muster. Seen the posts from TF and scooby doo and certainly have no intention of getting involved in any nonsense.outside of Scancell, horrified you guys do.

We all want the same thing here ultimately. happy to provide Scancell the task to make it happen on many fronts and into 2019. Best wishes to everybody else, catch yer around Xmas time. ATVB.

That was the hope of Scancell consistent now for many years.Increasingly the big Pharmas have been adopting that thought in recent years. That is in itself a welcoming shift in realism. The speed in with the health industry is adopting early diagnosis seems to be moving on relentlessly.

Good to see Scancell tweets back in number, as we prepare for our platforms to move into clinical trials, that will be key for us, lets hope it is not too far from happening.james Alisons Nobel prize has certainly put the spotlight on immunotherapy, obviously a good thing.

Buys 100k

Sells 114k

MMs will still take 100k at 7.85

Paid 8,700

07/12/2018 09:27 50,000 8.27
07/12/2018 08:37 11,118 8.212

7.70/8.50

07/12/2018 08:37 11,118 8.212

And never say never is what the scientists do. This RNS was published frmo Roche this morning, note initial treatment.........................................

https://www.investegate.co.uk/f--hoffmann-la-roche-ltd/gnw/fda-approves-roche-s-tecentriq-in-combination-with-avastin-and-chemotherapy-for-the-initial-treatment-of-people-with-a-specific-type-of-metastatic-lung-cancer/20181207060030H8219/

Appreciate you guys discussing MM codes which we do every year or so anyway. There are numerous articles, books on the subject, the common link is they are nearly all from years ago......this being just one example....................##

https://investorshub.advfn.com/PennyRunners-9223/

As i say i have an open mind to some form of codes which might well have evolved over the years, and it was my understanding that mobile phones were not allowed on the trading floor. Happy to keep an open mind, the mysteries of the trading floor might always be just that.......unknown.

Thanks for your input anyway.

Buys 20k

Sells 14k

Ray, that is why i asked you, you really do sound very confidant As i have said a few times just getting so far with the quality of team we have is a success, what a gamechanger if we can pull that off.

Knowlesi, i did post this.....................That we don"t know. I really don"t believe in most of the so called historic codes, but the 100 and 500 are interesting ones and just have an open mind to them. From 7.50 to 8.212 in less than 24 hours hardly constitues
"""The price dropping would suggest not""

There are huge parts of the market which you are far better informed than me on, as i have said to you, I2m presuming you are not happy with me disputing the price is dropping. Does it really need an interreagation????

Thanks Ray, appreciate that.